Syntara (ASX: SNT) Share Price

SNT

$0.024–+0.00%

$36.0MRank #1117 on ASXHealthcareDrug Manufacturers - Specialty & Generic

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$36.0M

Volume

328K

P/E Ratio

EPS

$0.00

Dividend Yield

0.00%

52-Week High

$0.083

52-Week Low

$0.023

Beta

0.142

Syntara (ASX: SNT) is an Australian-listed company in the Healthcare sector with a market capitalisation of $36.0M and the 1117th-largest security on the ASX by market capitalisation. The SNT share price is $0.024, up 0.00% today and down 64.71% over the past 12 months. Shares have traded between $0.023 and $0.083 over the past 52 weeks. In its most recent reported period (ending 30 June 2025), Syntara reported revenue of $0 and a net loss of $7.9M.

Charts

$0.02

24H Range

$0.023

$0.024

52-Week Range

$0.023

$0.083

About Syntara Limited

Syntara Limited is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies by targeting extracellular matrix dysfunction, primarily through amine oxidase chemistry. Headquartered in Frenchs Forest, Australia, the company's research pipeline focuses on blood cancers as well as a range of inflammatory and fibrotic disorders. Its leading investigational compound, amsulostat, is currently in Phase 1c/2 clinical trials for the treatment of myelofibrosis, a bone marrow cancer, and is also being evaluated for myelodysplastic syndrome. Beyond this, Syntara is advancing several other promising drug candidates. These include a suite of topical pan-LOX inhibitors: SNT-9465, which is undergoing Phase 1a/b study for hypertrophic scars, and SNT-6302, designed for keloid scars. Furthermore, SNT-4728 is in development to manage sleep disorders and to potentially slow the progression of neurodegenerative conditions by mitigating neuroinflammation. The company's broader therapeutic ambitions extend to various fibrotic and inflammatory diseases such as kidney fibrosis, MASH (metabolic dysfunction-associated steatohepatitis), pulmonary fibrosis, and cardiac fibrosis. Incorporated in 1998, the company was formerly known as Pharmaxis Ltd before adopting the name Syntara Limited in December 2023.

IPO Date

28 Nov 2023

CEO

Gary Jonathan Phillips

Employees

Website

syntaratx.com.au

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-7.9M
Total Assets	$21.4M
Total Debt	$84,000
Free Cash Flow	$-11.1M
Return on Equity	-49.44%
Profit Margin	—
Operating Margin	—

SNT Frequently Asked Questions

What is the Syntara (ASX: SNT) share price?

The SNT share price is $0.024, up 0.00% for the day, based on the latest available ASX market data.

What is Syntara's market capitalisation?

Syntara has a market capitalisation of $36.0M, making it the 1117th-largest security listed on the ASX.

Does Syntara pay a dividend?

SNT does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Syntara profitable?

In its most recent reported period (ending 30 June 2025), SNT reported revenue of $0 and a net loss of $7.9M.

How many SNT shares are on issue?

Syntara has approximately 1,500,200,000 shares on issue, based on its market capitalisation of $36.0M and current share price.

What sector is Syntara in?

Syntara is classified in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry on the ASX.

When did Syntara list on the ASX?

Syntara listed on the Australian Securities Exchange on 28 Nov 2023.

Latest News

Insights: Syntara Ltd (ASX:SNT)

smallcaps.com.au30 Oct 2025

Insights: Syntara Ltd (ASX:SNT) smallcaps.com.au

Syntara Limited Extends Trading Halt Following Favourable FDA Review and Planned Capital Raising

Sharecafe28 Apr 2026

Syntara Limited Extends Trading Halt Following Favourable FDA Review and Planned Capital Raising Sharecafe

Syntara Receives Positive FDA Feedback for Myelofibrosis Drug Amsulostat

Sharecafe28 Apr 2026

Syntara Receives Positive FDA Feedback for Myelofibrosis Drug Amsulostat Sharecafe

ASX Biotech Pause: Why Syntara Hit the Brakes Before Key Update

Kalkine Media27 Apr 2026

ASX Biotech Pause: Why Syntara Hit the Brakes Before Key Update Kalkine Media

Syntara Limited (ASX:SNT)

intelligentinvestor.com.au7 Dec 2023

Syntara Limited (ASX:SNT) intelligentinvestor.com.au

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
EPNEpsilon Healthcare Limited	$8.9M	$0.023	3.96	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.023	$0.024	$0.023	$0.024	174K	–+0.00%
11 June 2026	$0.026	$0.026	$0.023	$0.024	3.1M	▼-4.00%
10 June 2026	$0.025	$0.025	$0.024	$0.025	1.4M	▲+4.17%
9 June 2026	$0.025	$0.025	$0.024	$0.024	846K	▼-4.00%
8 June 2026	$0.026	$0.026	$0.025	$0.025	5M	–+0.00%
5 June 2026	$0.026	$0.026	$0.025	$0.025	4.9M	–+0.00%
4 June 2026	$0.026	$0.026	$0.025	$0.025	1.4M	▼-7.41%
3 June 2026	$0.027	$0.027	$0.027	$0.027	92K	–+0.00%
2 June 2026	$0.026	$0.027	$0.026	$0.027	725K	▲+3.85%
1 June 2026	$0.027	$0.027	$0.026	$0.026	60K	–+0.00%
29 May 2026	$0.027	$0.027	$0.026	$0.026	1.4M	–+0.00%
28 May 2026	$0.026	$0.026	$0.026	$0.026	2.4M	–+0.00%
27 May 2026	$0.026	$0.026	$0.026	$0.026	2.4M	–+0.00%
26 May 2026	$0.026	$0.026	$0.026	$0.026	134K	–+0.00%
25 May 2026	$0.026	$0.026	$0.025	$0.026	517K	–+0.00%
22 May 2026	$0.025	$0.026	$0.025	$0.026	748K	▲+4.00%
21 May 2026	$0.025	$0.026	$0.024	$0.025	349K	–+0.00%
20 May 2026	$0.026	$0.027	$0.025	$0.025	8.7M	▼-3.85%
19 May 2026	$0.027	$0.027	$0.026	$0.026	832K	–+0.00%
18 May 2026	$0.026	$0.027	$0.026	$0.026	1M	▼-3.70%
15 May 2026	$0.026	$0.027	$0.026	$0.027	1.7M	▲+3.85%
14 May 2026	$0.026	$0.026	$0.026	$0.026	219K	–+0.00%
13 May 2026	$0.027	$0.027	$0.026	$0.026	2.6M	–+0.00%
12 May 2026	$0.026	$0.027	$0.026	$0.026	1.6M	–+0.00%
11 May 2026	$0.026	$0.026	$0.026	$0.026	731K	▲+4.00%
8 May 2026	$0.028	$0.028	$0.025	$0.025	11M	▼-7.41%
7 May 2026	$0.027	$0.028	$0.027	$0.027	4.4M	–+0.00%
6 May 2026	$0.028	$0.028	$0.027	$0.027	448K	–+0.00%
5 May 2026	$0.028	$0.029	$0.027	$0.027	3.3M	▼-6.90%
4 May 2026	$0.029	$0.029	$0.028	$0.029	469K	–+0.00%

About Syntara Limited

IPO Date

28 Nov 2023

CEO

Gary Jonathan Phillips

Employees

Website

syntaratx.com.au

SNT Frequently Asked Questions

What is the Syntara (ASX: SNT) share price?

The SNT share price is $0.024, up 0.00% for the day, based on the latest available ASX market data.

What is Syntara's market capitalisation?

Syntara has a market capitalisation of $36.0M, making it the 1117th-largest security listed on the ASX.

Does Syntara pay a dividend?

SNT does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Syntara profitable?

In its most recent reported period (ending 30 June 2025), SNT reported revenue of $0 and a net loss of $7.9M.

How many SNT shares are on issue?

Syntara has approximately 1,500,200,000 shares on issue, based on its market capitalisation of $36.0M and current share price.

What sector is Syntara in?

Syntara is classified in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry on the ASX.

When did Syntara list on the ASX?

Syntara listed on the Australian Securities Exchange on 28 Nov 2023.

Company

Market Cap

Price

P/E

Div Yield

1D Change

EPNEpsilon Healthcare Limited

$8.9M

$0.023

3.96

0.00%

–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.023	$0.024	$0.023	$0.024	174K	–+0.00%
11 June 2026	$0.026	$0.026	$0.023	$0.024	3.1M	▼-4.00%
10 June 2026	$0.025	$0.025	$0.024	$0.025	1.4M	▲+4.17%
9 June 2026	$0.025	$0.025	$0.024	$0.024	846K	▼-4.00%
8 June 2026	$0.026	$0.026	$0.025	$0.025	5M	–+0.00%
5 June 2026	$0.026	$0.026	$0.025	$0.025	4.9M	–+0.00%
4 June 2026	$0.026	$0.026	$0.025	$0.025	1.4M	▼-7.41%
3 June 2026	$0.027	$0.027	$0.027	$0.027	92K	–+0.00%
2 June 2026	$0.026	$0.027	$0.026	$0.027	725K	▲+3.85%
1 June 2026	$0.027	$0.027	$0.026	$0.026	60K	–+0.00%
29 May 2026	$0.027	$0.027	$0.026	$0.026	1.4M	–+0.00%
28 May 2026	$0.026	$0.026	$0.026	$0.026	2.4M	–+0.00%
27 May 2026	$0.026	$0.026	$0.026	$0.026	2.4M	–+0.00%
26 May 2026	$0.026	$0.026	$0.026	$0.026	134K	–+0.00%
25 May 2026	$0.026	$0.026	$0.025	$0.026	517K	–+0.00%
22 May 2026	$0.025	$0.026	$0.025	$0.026	748K	▲+4.00%
21 May 2026	$0.025	$0.026	$0.024	$0.025	349K	–+0.00%
20 May 2026	$0.026	$0.027	$0.025	$0.025	8.7M	▼-3.85%
19 May 2026	$0.027	$0.027	$0.026	$0.026	832K	–+0.00%
18 May 2026	$0.026	$0.027	$0.026	$0.026	1M	▼-3.70%
15 May 2026	$0.026	$0.027	$0.026	$0.027	1.7M	▲+3.85%
14 May 2026	$0.026	$0.026	$0.026	$0.026	219K	–+0.00%
13 May 2026	$0.027	$0.027	$0.026	$0.026	2.6M	–+0.00%
12 May 2026	$0.026	$0.027	$0.026	$0.026	1.6M	–+0.00%
11 May 2026	$0.026	$0.026	$0.026	$0.026	731K	▲+4.00%
8 May 2026	$0.028	$0.028	$0.025	$0.025	11M	▼-7.41%
7 May 2026	$0.027	$0.028	$0.027	$0.027	4.4M	–+0.00%
6 May 2026	$0.028	$0.028	$0.027	$0.027	448K	–+0.00%
5 May 2026	$0.028	$0.029	$0.027	$0.027	3.3M	▼-6.90%
4 May 2026	$0.029	$0.029	$0.028	$0.029	469K	–+0.00%